Health Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as… James Pereira Jul 20, 2023 SHANGHAI, China, July 19, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX:… Read More...
Health Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in… James Pereira Jul 17, 2023 FORT LEE, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co.,… Read More...
Health Tempest to Report Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in… James Pereira Apr 28, 2023 <!-- Name:DistributionId Value:8827692 --> <!--… Read More...
Health Antimicrobial use in agriculture can breed bacteria resistant to first-line human defenses James Pereira Apr 28, 2023 Drug-resistant infections are one of the most serious threats to global health, and there is an urgent need to develop… Read More...
Health Including Anti-PD-1 in First-Line Ups Survival in Biliary Tract Cancer James Pereira Apr 18, 2023 ORLANDO -- Adding pembrolizumab (Keytruda) to first-line… Read More...
Health FDA Greenlights New First-Line Regimen in Bladder Cancer James Pereira Apr 4, 2023 The FDA gave… Read More...
Health FDA Panel Endorses New First-Line Lymphoma Regimen James Pereira Mar 10, 2023 Despite the concerns… Read More...
Health Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC James Pereira Feb 18, 2023 SAN FRANCISCO -- Adding the PARP inhibitor olaparib… Read More...
Health Ibrutinib Highly Effective as First-Line Mantle Cell Lymphoma Treatment James Pereira Feb 17, 2023 Results of a large randomized trial… Read More...
Business New Analyses Reinforce Survival Benefit of BAVENCIO First-Line Maintenance Treatment in Patients… Nick J Adam Feb 14, 2023 This section is Partnership Content supplied The content in this section is supplied by Business Wire for… Read More...